Boston Scientific to Participate in 38th Annual Canaccord Genuity Growth Conference

 

MARLBOROUGH, Mass., July 30, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 38th Annual Canaccord Genuity Growth Conference on Wednesday, August 8, 2018 in Boston.

Susie Lisa, vice president, Investor Relations, and Lindsay Fish, director, Investor Relations, will participate in a 25-minute question-and-answer session with the host analyst beginning at approximately 9:00 a.m. EDT. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. A replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

    CONTACTS

    Media:                        Investors:

    Kate Haranis                  Susie Lisa, CFA

    508-683-6585 (office)         508- 683-5565 (office)

    Media Relations               Investor Relations

    Boston Scientific Corporation Boston Scientific Corporation

    Kate_Haranis@bsci.com         BSXInvestorRelations@bsci.com

 

View original content with multimedia:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-38th-annual-canaccord-genuity-growth-conference-300688517.html

SOURCE Boston Scientific Corporation

Company Codes: NYSE:BSX

Back to news